Galapagos NV
GLPG
#4542
Rank
โ‚ฌ1.82 B
Marketcap
27,70ย โ‚ฌ
Share price
-1.60%
Change (1 day)
15.79%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.82 Billion

As of March 2026 Galapagos NV has a market cap of โ‚ฌ1.82 Billion. This makes Galapagos NV the world's 4542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.82 B-1.3%
2025โ‚ฌ1.85 B7.18%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

End of Day market cap according to different sources

On Mar 19th, 2026 the market cap of Galapagos NV was reported to be:

โ‚ฌ1.85 Billion
by Nasdaq info icon info icon
โ‚ฌ1.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ490.75 B 26,735.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ158.55 B 8,570.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ313.72 B 17,054.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ93.97 B 5,038.89%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ244.24 B 13,255.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ246.26 B 13,366.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ90.08 B 4,825.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ80.29 M-95.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.94 B 1,483.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel